Key statistics
On Thursday, Olema Pharmaceuticals Inc (OLMA:NSQ) closed at 13.60, -23.56% below its 52-week high of 17.79, set on Nov 08, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 13.15 |
---|---|
High | 13.67 |
Low | 12.91 |
Bid | 10.80 |
Offer | 15.50 |
Previous close | 12.81 |
Average volume | 492.14k |
---|---|
Shares outstanding | 57.27m |
Free float | 55.19m |
P/E (TTM) | -- |
Market cap | 778.82m USD |
EPS (TTM) | -2.06 USD |
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
- Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Olema Oncology to Participate in Morgan Stanley 22nd Annual Global Healthcare Conference
- Olema Oncology Reports Second Quarter 2024 Financial Results and Provides Corporate Update
- Olema Oncology to Participate in Upcoming Investor Conferences in June
- Olema Oncology Announces Promising New Data for Palazestrant in Combination with Ribociclib Presented at the 2024 ESMO Breast Cancer Congress
- Olema Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update
- Olema Oncology Announces New Clinical Data for Palazestrant in Combination with Ribociclib to be Presented at the 2024 ESMO Breast Cancer Annual Congress
- Olema Oncology to Participate in Upcoming Investor Conferences in May
- Olema Oncology to Participate in Canaccord Genuity 2024 Horizons in Oncology Virtual Conference
- Olema Oncology Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Update
More ▼